Barclays Reiterates an 'Overweight' on Regeneron Pharma (REGN); Sticking with VTE Ahead of CATT Data
Go back to Barclays Reiterates an 'Overweight' on Regeneron Pharma (REGN); Sticking with VTE Ahead of CATT Data| Regeneron (NASDAQ: REGN) | Delayed: 834.04 +7.40 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $826.64 | 52 Week High | $592.36 | |||
| Open | $835.74 | 52 Week Low | $325.35 | |||
| Day High | $847.00 | P/E | 218.91 | |||
| Day Low | $826.64 | EPS | $3.81 | |||
| Volume | 786,870 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.85 +0.70 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.15 | 52 Week High | $44.76 | |||
| Open | $45.26 | 52 Week Low | $36.81 | |||
| Day High | $46.11 | P/E | N/A | |||
| Day Low | $45.25 | EPS | $0.00 | |||
| Volume | 1,860,731 | |||||
